14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:OCRX
Delisted

Ocera Therapeutics Fund Price (Quote)

$1.79
+0 (+0%)
At Close: Jan 16, 2018

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 16th Jan 2018 OCRX stock ended at $1.79. During the day the stock fluctuated 0% from a day low at $1.79 to a day high of $1.79.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Ocera Therapeutics prices

Date Open High Low Close Volume
Jan 16, 2018 $1.79 $1.79 $1.79 $1.79 0
Jan 15, 2018 $1.79 $1.79 $1.79 $1.79 0
Jan 12, 2018 $1.79 $1.79 $1.79 $1.79 0
Jan 11, 2018 $1.79 $1.79 $1.79 $1.79 0
Jan 10, 2018 $1.79 $1.79 $1.79 $1.79 0
Jan 09, 2018 $1.79 $1.79 $1.79 $1.79 0
Jan 08, 2018 $1.79 $1.79 $1.79 $1.79 0
Jan 05, 2018 $1.79 $1.79 $1.79 $1.79 0
Jan 04, 2018 $1.79 $1.79 $1.79 $1.79 0
Jan 03, 2018 $1.79 $1.79 $1.79 $1.79 0
Jan 02, 2018 $1.79 $1.79 $1.79 $1.79 0
Dec 29, 2017 $1.79 $1.79 $1.79 $1.79 0
Dec 28, 2017 $1.79 $1.79 $1.79 $1.79 0
Dec 27, 2017 $1.79 $1.79 $1.79 $1.79 0
Dec 26, 2017 $1.79 $1.79 $1.79 $1.79 0
Dec 22, 2017 $1.79 $1.79 $1.79 $1.79 0
Dec 21, 2017 $1.79 $1.79 $1.79 $1.79 0
Dec 20, 2017 $1.79 $1.79 $1.79 $1.79 0
Dec 19, 2017 $1.79 $1.79 $1.79 $1.79 0
Dec 18, 2017 $1.79 $1.79 $1.79 $1.79 0
Dec 15, 2017 $1.79 $1.79 $1.79 $1.79 0
Dec 14, 2017 $1.79 $1.79 $1.79 $1.79 0
Dec 13, 2017 $1.79 $1.79 $1.79 $1.79 0
Dec 12, 2017 $1.79 $1.79 $1.79 $1.79 0
Dec 11, 2017 $1.79 $1.79 $1.79 $1.79 0
Click to get the best stock tips daily for free!

About Ocera Therapeutics

Ocera Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the development and commercialization of OCR-002, which is in Phase IIb trials for the treatment of hyperammonemia and hepatic encephalopathy in patients with liver cirrhosis, acute liver injury, and acute liver failure, as well as in the areas of unmet medical need. The company is headquartered in Palo Alto, California.... OCRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT